MCCANN COREY (President and CEO) sold 0.4% of their position (34.73K shares) of PEAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $39.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/24/2023ACC: 0001062993-23-001323
DirectorOfficer· President and CEO
Since Dec 2021
-34.73K
Net shares
Net seller
$39.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
34.73K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−34.73K
Price / share
$1.13
Trade value
$39.25K
% of position
0.4%
1/20/2023
8.25M→8.21M
Total
Net shares
−34.73K
Net value
-$39.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 1/20/2023 | S · Sale | −34.73K | $1.13 | $39.25K | 0.4% | 8.25M | 8.21M |
| Total | −34.73K | -$39.25K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Class A Common Stock
IndirectShares owned986.52K
Class A Common Stock
IndirectShares owned1.69M
Total
2.67M indirect2.67M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 986.52K | Indirect |
| Class A Common Stock | 1.69M | Indirect |
| Total | 2.67M | 2.67M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported